Watch an informative Fox-29 TV news report segment on the Temple COPD disease management study, featuring interviews with a patient and a study coordinator.

"With the (LogPad) you have a daily routine, seven days a week, so you can't miss it. You can't go wrong … This here keeps me out of the hospital as much as possible. That's what I love about it."

Edward Goldwire
COPD patient

Read more on what people are saying about PHT.

Experience Counts

There is always a reason why one technology provider has much more experience than any other - because time and again, clients performing due diligence determine that company's solution to be the most comprehensive and reliable. As this global experience accumulates, the provider learns from unique situations and develops best practices that other companies can't match. This results in efficient delivery and even more beneficial solutions for its clients.

Solution Design

PHT has more experience with unique specifications and therapeutic areas than any other ePRO provider, and it shows. One of the key tangible benefits of our experience is the learned ability to create innovative diary designs that address a wide variety of clinical needs. PHT's scientific team - consisting of Steve Raymond, Ph.D., Valdo Arnera, MD, and Barbara Marino, Ph.D., RN - works closely on every client engagement to ensure we design an effective and scientifically compelling ePRO solution.

Experience in Action

Once the design is complete, PHT's internal Production team uses proprietary tools to manage worldwide logistics as part of our Trial Success Program. Meanwhile, expert Project Managers and the Study Support Center make sure your trial is on track from First Patient In through trial close-out and site regulatory audit. Our validated technical system is unrivaled in its security measures, and has been fine-tuned over the years to serve as bullet-proof protection of data integrity. In this way, PHT's market-leading experience gives sponsors peace of mind that their critical patient data is in trusted hands.

Going Global

It is certainly impressive to review the LogPad's list of supported languages and countries, but what are the benefits of such broad experience to study sponsors working with PHT?

  1. Because our core LogPad library has been translated and validated into so many languages, in most cases only the study-specific diaries and certain questionnaires will require translation
  2. We understand technology shipping and customs requirements for countries around the world, which helps us set accurate timelines and expectations for global delivery.
  3. For both the LogPad and the StudyPad, it's possible to select different languages for the site and subject. Experience has demonstrated a portion of sites will recruit patients speaking a variety of native languages in global studies.
  4. We can implement up to 16 languages on one eDiary file, if more are required, will break up the languages strategically to ensure the right devices go to the correct countries. This reduces hardware costs and eases site administration.
  5. We have a validated translation process, and have been working with our validated translation partner, TransPerfect for 8 years. Each translation is validated by two independent translators, backward and forward, to ensure subjects can understand exactly what sponsors are asking.

The bottom line is PHT's international experience leads to a higher-quality study, with a faster delivery, reduced cost and less risk for sponsors.

LogPads Around the World

ORANGE = LogPads/StudyPads deployed by PHT in sponsored clinical research.
GREEN = We'll be there soon.
BLUE = Oceans and seas.

PHT has significant experience with a wide range of indications and standardized questionnaires. This has enabled us to develop therapeutic area-specific design best practices for highly diverse trials. While we understand you know your science best, this experience helps our eDiary experts make strategic design recommendations to improve your study.

The vast majority of PHT's trial experience (80%) comes from Phase II and III studies. Often, a company will work with us in Phase II and, once they realized the benefits of the LogPad firsthand, carry our solution over as their study moves to Phase III. We also have experience with pilots, Phase I and post-marketing Phase IV studies, including the largest ePRO trial to date with over 20,000 patients and 4,000 sites.

Learn More about PHT's Trial Experience

In what other ways will PHT's experience benefit my trial? What experience do you have with studies similar to mine? Contact PHT for answer to these questions or any others you may have.

Contact Us Products & Solutions Experience PHT Why ePRO? Resources Company Sitemap
® 2007 PHT Corporation